Clinical experience with impromidine, a highly specific H2-receptor agonist

Area of Science:

• Pharmacology
• Gastroenterology
• Histamine Receptor Research

Background:

• Peptic ulcer disease and dyspepsia involve gastric acid secretion.
• Histamine H2 receptors play a role in regulating gastric acid production.
• Selective histamine H2 agonists are valuable research tools.

Purpose of the Study:

• To evaluate the gastric secretory response to impromidine, a selective histamine H2 agonist.
• To compare impromidine's efficacy with pentagastrin in stimulating gastric acid output.
• To assess the safety and tolerability of impromidine in different age groups.

Main Methods:

• A study involving 40 patients with peptic ulcer disease or ulcer-like dyspepsia.
• Intravenous and subcutaneous administration of impromidine and pentagastrin.
• Measurement of peak acid output following drug administration.
• Cardiovascular monitoring in younger and elderly patient cohorts.

Main Results:

• No significant difference in peak acid output between impromidine and pentagastrin via intravenous or subcutaneous routes.
• Impromidine was well tolerated with minimal cardiovascular effects.
• The drug was safely administered to both younger patients and elderly subjects with pre-existing cardiovascular conditions.

Conclusions:

• Impromidine elicits a gastric secretory response comparable to pentagastrin.
• Impromidine demonstrates good tolerability, even in elderly individuals.
• This histamine H2 agonist is a promising tool for investigating histamine's role at H2 receptors in humans.